Research is exploring the role of dendritic cells in shaping the fate of CD8+ T cells in cancer, with studies examining their function in the tumor microenvironment and potential for targeted immunotherapy. The interaction between dendritic cells and CD8+ T cells is being investigated in relation to antitumor immunity and T cell exhaustion. Various factors, including metabolic reprogramming and immune crosstalk, are also being studied for their impact on cancer immunity.